These findings warrant further investigation, particularly regarding the specific roles of CD3+ and Foxp3+ cells in tumor progression and their interactions with tumor cells and other immune cells.CD4+ and CD8+ T cells are generally regarded as the central players in anti-tumor immunity (37, 38). This evidence concerns the gene FOXP3 and neoplasm.